Erste Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Erste Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60,000	Closed	-$447K	–	569
2022 Q3	$447K	Hold	60,000	–	–	0.01%	432
2022 Q2	$617K	Hold	60,000	–	–	0.01%	407
2022 Q1	$743K	Buy	60,000 +30,000	+100%	+$464K	0.01%	388
2021 Q4	$675K	Hold	30,000	–	–	0.01%	399
2021 Q3	$690K	Hold	30,000	–	–	0.01%	372
2021 Q2	$392K	Hold	30,000	–	–	0.01%	437
2021 Q1	$376K	Hold	30,000	–	–	0.01%	408
2020 Q4	$418K	Sell	30,000 -61,000	-67%	-$888K	0.01%	403
2020 Q3	$1.32M	Buy	91,000 +25,000	+38%	+$362K	0.05%	287
2020 Q2	$1M	Hold	66,000	–	–	0.04%	294
2020 Q1	$970K	Hold	66,000	–	–	0.06%	257
2019 Q4	$1.41M	Buy	+66,000	New	+$608K	0.06%	241

Other funds holding AUPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Erste Asset Management's AUPH Position: Q4 2022 in Review

Erste Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 60,000 shares — an estimated $447K sold.

Erste Asset Management first reported a position in AUPH in Q4 2019 and held it in 12 quarters. The position peaked at $1.41M in Q4 2019. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

Erste Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Erste Asset Management sold 60,000 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $447K.
Erste Asset Management first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 12 quarters.
Erste Asset Management's Aurinia Pharmaceuticals position peaked at $1.41M in Q4 2019.
191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Erste Asset Management's 13F filing for Q4 2022, filed 26 Nov 2024.